Immunogenic polypeptides encoded by mage minigenes and uses thereof

Details for Australian Patent Application No. 2001258102 (hide)

Owner Aventis Pasteur Limited Ludwig Institute for Cancer Research

Inventors Berinstein, Neil; Tine, John A; BoonFalleur, Thierry; Moingeon, Philippe; Tartaglia, Jim; Van Der Bruggen, Pierre

Agent Spruson & Ferguson

Pub. Number AU-B-2001258102

PCT Pub. Number WO01/85932

Priority 60/242,388 20.10.00 US; 60/202,970 10.05.00 US; 60/203,578 11.05.00 US

Filing date 7 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 1 March 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

1 March 2007 Application Accepted

  Published as AU-B-2001258102

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001258103-Security system for high level transactions between devices

2001258101